Next Article in Journal
Myrtaceae in Australia: Use of Cryobiotechnologies for the Conservation of a Significant Plant Family under Threat
Next Article in Special Issue
Does Abiotic Host Stress Favour Dothideomycete-Induced Disease Development?
Previous Article in Journal
Genome-Wide Identification and Expression Analysis of XTH Gene Family during Flower-Opening Stages in Osmanthus fragrans
Previous Article in Special Issue
Genetic Characteristics and Metabolic Interactions between Pseudocercospora fijiensis and Banana: Progress toward Controlling Black Sigatoka
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Targeted Gene Mutations in the Forest Pathogen Dothistroma septosporum Using CRISPR/Cas9

by
Hannah M. McCarthy
1,*,
Mariana Tarallo
1,
Carl H. Mesarich
2,
Rebecca L. McDougal
3 and
Rosie E. Bradshaw
1
1
BioProtection Aotearoa, School of Natural Sciences, Massey University, Palmerston North 4472, New Zealand
2
BioProtection Aotearoa, School of Agriculture and Environment, Massey University, Palmerston North 4472, New Zealand
3
Scion, New Zealand Forest Research Institute Ltd., Rotorua 3010, New Zealand
*
Author to whom correspondence should be addressed.
Plants 2022, 11(8), 1016; https://doi.org/10.3390/plants11081016
Submission received: 25 February 2022 / Revised: 4 April 2022 / Accepted: 4 April 2022 / Published: 8 April 2022
(This article belongs to the Special Issue Pathogenic Dothideomycete-Plant Interactions)

Abstract

:
Dothistroma needle blight, caused by Dothistroma septosporum, has increased in incidence and severity over the last few decades and is now one of the most important global diseases of pines. Disease resistance breeding could be accelerated by knowledge of pathogen virulence factors and their host targets. However, this is hindered due to inefficient targeted gene disruption in D. septosporum, which is required for virulence gene characterisation. Here we report the first successful application of CRISPR/Cas9 gene editing to a Dothideomycete forest pathogen, D. septosporum. Disruption of the dothistromin pathway regulator gene AflR, with a known phenotype, was performed using nonhomologous end-joining repair with an efficiency of >90%. Transformants with a range of disruption mutations in AflR were produced. Disruption of Ds74283, a D. septosporum gene encoding a secreted cell death elicitor, was also achieved using CRISPR/Cas9, by using a specific donor DNA repair template to aid selection where the phenotype was unknown. In this case, 100% of screened transformants were identified as disruptants. In establishing CRISPR/Cas9 as a tool for gene editing in D. septosporum, our research could fast track the functional characterisation of candidate virulence factors in D. septosporum and helps set the foundation for development of this technology in other forest pathogens.

1. Introduction

The ability to specifically mutate genes of interest is of utmost importance to our understanding of how plant pathogens cause disease, and it is based on the careful analysis of interaction phenotypes observed between pathogen mutants and their plant hosts. The pathogen–host interaction database (PHI-base) exemplifies this approach by providing an inventory of curated pathogen gene mutations that affect disease phenotypes [1]. The increased availability of genome sequences and associated in planta transcriptome data facilitates the identification of candidate genes from plant pathogens that can be tested for roles in virulence, pathogenicity, or other types of interactions. However, the application of molecular tools such as targeted gene deletion or editing in forest pathology is almost nonexistent compared to their use in agricultural and horticultural settings [2,3].
Some Dothideomycete fungi are pathogens of forest trees, and among these are Dothistroma septosporum and its sister species Dothistroma pini, which cause Dothistroma needle blight (DNB) of pines and some other Pinaceae species [4]. DNB is globally one of the most important pine diseases, and increases in incidence and severity are associated with changes in the climate [4,5]. Learning more about how these pathogens interact with their hosts could help in breeding or selection for disease resistance, and in developing new tools for disease management [3,6].
Genomic and transcriptomic resources for D. septosporum [7,8] enabled the identification of candidate virulence genes [6]. Targeted gene mutation is regularly performed in D. septosporum using the traditional method of homologous recombination based on protoplast transformation, with the aim of determining gene function. For example, genes involved in the biosynthesis of the anthraquinone toxin dothistromin were deleted by this method and showed dothistromin to be a virulence factor in DNB [9]. Other deleted D. septosporum genes include potential virulence and avirulence genes [3,10], and those involved in gene regulation [11,12]. However, in D. septosporum, the homologous recombination method is inefficient, with only a small proportion of transformants being gene knockout mutants. The development of CRISPR/Cas9 technology for targeted gene modification and its success in filamentous fungi [13,14] led to our CRISPR/Cas9 trial in D. septosporum.
Clustered regularly interspaced short palindromic repeats (CRISPR) is part of an adaptive immune system in prokaryotes that protects against invasion from phages and plasmids [15,16]. CRISPR operates through two main components: Cas nuclease proteins, which cut the DNA to produce a double-stranded break (DSB), and CRISPR RNAs (crRNAs), which direct the Cas protein [17] to the protospacer adjacent motif (PAM) site [18]. In prokaryotes, the genetic memory of previous viral invasions can be stored as CRISPR spacers and used to enable crRNAs to defend against subsequent invasions [16,18]. For the use of CRISPR/Cas9 as a gene editing technology, crRNA is adapted into a single-guide RNA (sgRNA) [19] and designed to match to an existing PAM site in the target gene, allowing for specific gene editing [19,20].
Since the first report of CRISPR/Cas9 gene editing in filamentous fungi [13], this technology has been used in many different fungal species [21], including plant pathogens [2,22]. Pathogenic Dothideomycete species where CRISPR/Cas9 technology was successfully applied include Alternaria alternata [23], Leptosphaeria maculans [24], Parastagonospora nodorum [25]. and Venturia inaequalis [26]. In P. nodorum, CRISPR/Cas9 gene editing technology was recently used to characterise the SnTox5 gene, showing that it encodes a virulence factor responsible for inducing programmed cell death and facilitating mesophyll colonisation in wheat [27].
Here, we set out to establish the CRISPR/Cas9 gene editing system in D. septosporum using synthetic sgRNA to obtain AflR gene mutants (Joint Genome Institute (JGI) ID: Ds75566). AflR is the pathway regulator gene for the biosynthesis of the dothistromin virulence factor [28]. Mutants with a disrupted AflR gene have a dothistromin-deficient phenotype, based on an earlier study that involved gene replacement using traditional homologous recombination methods [28]. We also trialled the use of sgRNA with a donor DNA for CRISPR/Cas9-mediated homology-dependent repair to obtain mutants in a different gene whose mutant phenotype was unknown.

2. Results

2.1. Transformation of D. septosporum with CRISPR/Cas9 and sgRNAs Targeting AflR Yielded a High Percentage of Dothistromin-Deficient Transformants

D. septosporum was transformed using two different sgRNAs to increase the chance of obtaining an AflR gene mutant. After two rounds of subculturing on hygromycin B selective media, 1 transformant was obtained from sgRNA AflR1, and 47 transformants from sgRNA AflR2. From a preliminary phenotypic screen, 45 of these transformants (including the one from sgRNA AflR1) were suggested to be AflR knockouts because they had a dothistromin-deficient phenotype, as indicated by the absence of red-brown pigmentation in the surrounding media on which they were cultured. The three other transformants had a dothistromin-producing phenotype similar to the wild-type (WT) fungus. Representative samples are shown in Figure 1a.
As a starting point to verify which transformants were AflR mutants, and to identify which types of mutations were caused by CRISPR/Cas9 gene editing, PCR screening was performed using primers HM89 and HM90 that bind either side of AflR (Figure S1). Only four transformants gave a PCR product that was the same size as the WT fungus (1.6 kb); three of these had a dothistromin-producing phenotype in a visual screen (37, 45, and 144), while transformant 140 was dothistromin-deficient. Two transformants (145 and 158) gave larger PCR products than those of the WT fungus, while all other screened transformants either did not have a PCR product or had several nonspecific PCR products. Together, these results suggested that over 90% of the CRISPR/Cas9 transformants had a mutation in the AflR gene that led to the dothistromin-deficient phenotype.

2.2. A Single-Nucleotide Deletion and Insertions Ranging from 387 bp to 2.8 kb Were Identified among AflR CRISPR/Cas9 Transformants

The different types of mutations caused by CRISPR/Cas9 gene editing were investigated in a subset of ten transformants (all from sgRNA AflR2). Subset selection was based on transformants that gave a specific PCR product of WT size or larger, and a representative selection of transformants that displayed different patterns of nonspecific PCR amplification. Dothistromin phenotypes and thin-layer chromatography (TLC) profiles of these ten transformants showing the presence or absence of dothistromin are shown in Figure 1.
PCR analysis was then carried out using genomic DNA from the ten transformants (Figure 2), and selected PCR products were sequenced (Figure 3). Southern blot analysis with two restriction enzymes was also performed to confirm the results (Figure S3). As in the preliminary screen, PCR with primers HM89/HM90 gave a 1.6 kb product with genomic DNA from the WT fungus and transformants 45, 140, and 144 (Figure 2b). Sequencing of these PCR products confirmed that transformants 45 and 144 had the WT AflR sequence and are thereby not AflR disruptants, as suggested from their dothistromin-producing phenotype and TLC profile (Figure 1). Transformant 140 did not appear to produce dothistromin (Figure 1) despite the WT-sized PCR product, and sequencing identified a single adenine nucleotide deletion at the double-strand break (DSB) site, resulting in a frame-shift mutation (Figure 3b). These results were further supported by WT-sized fragments obtained from transformants 45, 140, and 144 in Southern hybridisations (Figure S3).
A PCR product larger than that from the WT fungus (1.6 kb) was amplified from transformants 82 (4.2 kb), 133 (3.5 kb), 145 (2 kb), and 158 (4.4 kb), consistent with the preliminary PCR screen (Figure 2b). Insertions of various sizes ranging from 387 nt to 2.8 kb were estimated from the AflR PCR (HM89/HM90) product sizes, with additional evidence from the full-sequence analysis of smaller PCR products (Figure 3). The site of insertion in these transformants was at the DSB site or up to 2 nt downstream towards the protospacer adjacent motif (PAM) site (Figure 3b). Southern hybridisation analysis of genomic DNA digested with HindIII or XhoI showed that each of these four insertion transformants (82, 133, 145, 158) lacked a band corresponding to the WT AflR gene, confirming their status as AflR mutants (Figure S3). Transformants 82, 133, and 158 had the expected XhoI fragments, but smaller HindIII hybridising bands than those expected, indicative of extra HindIII sites in the inserted DNA. Transformant 145 was unusual in showing larger hybridising bands for both HindIII and XhoI digests (Figure S3) despite being the transformant with the smallest insertion of 387 bp. These results are unusual and not supported by previous PCR analysis, suggesting that whole-genome sequencing is required to determine the full extent of CRISPR/Cas9 editing in this transformant.
Genomic DNA from transformants 105, 157, and 161 did not give a specific PCR product (Figure 2b), consistent with the preliminary PCR screen. It is possible that these transformants contain a large indel that could not be captured by the PCR screen using primers HM89 and HM90. To investigate this, primers were designed to amplify genes on either side of AflR: AflJ and Ds140271. As expected, the WT fungus and all transformants for which a PCR product was obtained from the AflR screen showed amplification of these two neighbouring genes. The genomic DNA of transformants 105, 157, and 161 also amplified AflJ and Ds140271 (Figure 2c). This suggested that, if these transformants each contained a large indel, it did not disrupt the genes located either side of AflR.
To identify the hypothesised indel in these three transformants (105, 157, 161), primers were designed at ~1 kb intervals between AflR and Ds140271 (Figure 2a). PCR amplification of the set of 10 transformants using the HM89 forward primer with each of the nested reverse primers HM183, HM184, HM185, and HM186 (Figure 2b) gave PCR products consistent with those expected on the basis of PCR results with the AflR gene HM89/HM90 primers. In some cases, PCR products were very faint or nonspecific bands were observed, the latter occurring in all samples for the widely spaced HM89/HM186 primer pair (the largest distance apart in this primer series). Interestingly, for putative large-indel transformants 105, 157, and 161, no PCRs involving the region spanning between AflR and Ds140270 gave a specific product. Southern hybridisation analysis of transformants 105, 157, and 161 confirmed the disruption of the WT AflR locus as expected. It also revealed differently sized fragments among the three transformants for each restriction enzyme (Figure S3), suggesting that these transformants were the products of independent insertion events with differently sized inserts and additional restriction enzyme recognition sites. It was not possible to estimate the insert sizes on the basis of available information. In summary, these results show that a variety of disruptions in AflR were produced from CRISPR/Cas9 gene editing in D. septosporum.

2.3. Insertions in Dothistroma septosporum AflR Transformants Match Components of the CRISPR/Cas9 Plasmid

Transformants with insertions that gave a larger product than that from the WT fungus in the AflR PCR (primers HM89/HM90) were analysed by PCR amplicon sequencing. The 387 bp insertion from transformant 145 was identified to match part of the CRISPR/Cas9 plasmid (Cas9HygAMAccdB) used in transformation, specifically the C-terminal region of the hygromycin B resistance gene (hph) and the trpC terminator of the hph cassette (Figure 4). Partial sequencing of the larger insertions in transformants 82 and 158 also showed matches to the hph cassette (Figure 4). PCR product size and sequence information suggested that the insertion in transformant 82 included the gpdA promoter and the full hph coding sequence, while the insertion in transformant 158 appeared to include the entire hph cassette but in the opposite orientation to the two other transformants (Figure 4). Transformants 82 and 158 thus both contained regions of the hph cassette that include a HindIII recognition site, accounting for the additional HindIII site predicted from the Southern hybridisation results (Figure S3). Transformant 133 contained an insertion that matched different parts of the CRISPR/Cas9 plasmid, including regions of the AMA1 autonomously replicating sequence, and parts of the Cas9 and ampicillin resistance (AmpR) genes, interspersed with a segment of DNA that was not from the plasmid but matched bacterial insertion (IS1) sequences, including those from Escherichia coli. Together, these results showed that, in several transformants, partial copies of the plasmid used for CRISPR/Cas9 editing in D. septosporum were inserted at the DSB.

2.4. Donor DNA Enables Homologous Recombination in CRISPR/Cas9 Mutation of a Putative Virulence Gene of Unknown Phenotype

Ds74283 is a small secreted protein from D. septosporum that triggers plant cell death in a nonhost species Nicotiana benthamiana and in the host species Pinus radiata (Figure S5), and is a putative virulence gene [6]. Ds74283 expression is strongly upregulated at the transcriptional level during mid and late in planta stages that mark the start and end of the necrotrophic stage of pine infection, when compared with the early (biotrophic) stage and growth in culture [8].
Unlike AflR, the mutant phenotype of Ds74283 was unknown, so a screen for targeted mutants based on phenotype was not possible. To maximise the chance of obtaining mutants, we transformed D. septosporum with plasmids containing donor DNA (dDNA) in addition to sgRNA that targets Ds74283. Using CRISPR/Cas9 alone with sgRNA requires the fungus to repair the DSB using nonhomologous end joining (NHEJ), which is an efficient but error-prone DNA repair pathway [29]. The other DNA repair system, homologous recombination, occurs in the presence of a template, generating a faithful copy of the template DNA. Therefore, an exogenous repair template, in this case, dDNA consisting of a resistance selection marker (nptII, which confers resistance to geneticin) flanked by Ds74283 sequences and designed to disrupt the gene, was delivered into the cell to allow for homologous recombination repair to occur (Figure 5a).
The co-transformation of D. septosporum with sgRNA and dDNA targeting Ds74283 produced 82 transformants, of which 42 were stable on selective hygromycin B and geneticin media. Of these, 17 were randomly selected to be single-spore purified in the presence of geneticin and maintained on nonselective medium. All 17 transformants showed the same visual phenotype as that of the WT fungus and were screened by PCR with two sets of primers that each spanned the Ds74283 gene (MT95/MT96 and MT97/MT98; Figure 5a). Compared to the WT fungus, all 17 D. septosporum transformants had PCR products that were 2.8 kb larger in size, as expected for gene disruption by homologous recombination (Figure 5b,c). Five transformants from five independent transformation plates were also analysed by PCR across the junctions of the flanking sequences and the inserted nptII geneticin resistance cassette (using primers MT97/MT99 and MT100/MT98) and results were consistent with disruption of Ds74283 by integration of the nptII gene (Figure S6).
The same set of five transformants (3, 25, 45, 52 and 56) were selected for verification by Southern hybridisation (Figure 5d,e). As expected, none of them showed hybridisation to fragment sizes corresponding to the WT fungus, suggesting the successful disruption of Ds74283. However, only two of the transformants (3 and 56) showed hybridisation to fragment sizes expected from integration of the nptII gene by homologous recombination at the disruption site. Moreover, all five transformants showed additional hybridising fragments that did not correlate with the predicted sizes from partial digests or insertion of whole dDNA plasmids. In summary, in all screened transformants, Ds74283 was disrupted, and Southern hybridisation analysis showed that, in two of them, it was possible to detect the expected disruption size band, although additional hybridising bands were present.

3. Discussion

This study showed that targeted disruption of the D. septosporum dothistromin regulator gene AflR and a gene encoding small secreted protein Ds74283 could be achieved using CRISPR/Cas9 technology. To the best of our knowledge, this is the first application of this technology in a Dothideomycete forest pathogen, and only the second in any forest pathogen, with a prior report of CRISPR/Cas9 editing being performed in the Dutch elm disease pathogen Ophiostoma novo-ulmi [30]. In D. septosporum, we report a high efficiency (>90%) of AflR gene disruption using CRISPR/Cas9 without a donor repair template, and 100% disruption of Ds74283 with a repair template in screened transformants. This finding greatly facilitates the functional analysis of genes identified from genomic and transcriptomic studies [8], as achieved with Dothideomycete pathogens Lasiodiplodia theobromae [31] and Leptosphaeria maculans [32], to characterise new virulence factors.
CRISPR/Cas9 transformation of D. septosporum to disrupt AflR was performed using two different sgRNAs. Despite having similar on-target scores, and the transformation being performed with the same conditions in the same experiment, significantly different numbers of colonies were obtained. While variability in sgRNA activity has been reported [26], our transformation strategy selected for the uptake of the autonomously replicating CRISPR/Cas plasmid rather than sgRNA activity. Therefore, the difference in the number of transformants obtained when using each sgRNA was likely due to differences in plasmid uptake and persistence.
The disruption of AflR was highly efficient using CRISPR/Cas9 with NHEJ repair; however, a range of transformant types was produced. Of the studied transformants, one had a single-nucleotide deletion, four had insertions ranging from 387 bp to 2.8 kb, and three had undefined disruptions. The gene editing of V. inaequalis using the same CRISPR/Cas9 transformation method also produced a variety of different mutant types, but had lower gene disruption efficiency of 16.7% [26].
Several D. septosporum AflR transformants contain insertions that matched part of the CRISPR/Cas9 plasmid used in transformation, specifically all or part of the hygromycin B resistance gene hph despite the CRISPR/Cas9 plasmid containing a fungal autonomously replicating sequence [26]. The insertion of a CRISPR plasmid into fungal transformants was first reported by Fuller et al. [33], who found the insertion of partial and complete copies of the transforming plasmid, resulting in larger insertions than those reported in this study. Subsequent studies consistently found the insertion of the complete plasmid at the DSB site [34] or the insertion of large plasmid fragments [35,36]. Fuller et al. [33] suggested that the insertion of the CRISPR plasmid or of partially degraded parts of the plasmid could occur at the DSB site through the NHEJ mechanism. More recent research suggested that the integration of CRISPR plasmids can occur following their cleavage with nucleases that are present in protoplast lysates during transformation, which allows for incorporation by the NHEJ mechanism, essentially using the cleaved plasmid product as a dDNA molecule [35]. All these studies that reported the insertion of partial or complete copies of a CRISPR plasmid [33,34,35,36] used protoplast transformation and hygromycin B selection. In our study, AflR transformants were cultured four times on hygromycin B selective media, providing strong selection for the stable integration of the hph gene. To reduce such integration events, it is preferable to subculture on a nonselective medium after the first round of selection on transformation plates.
In CRISPR/Cas9 homology-directed repair, DSB repair is based on complementarity with a dDNA template, in most cases resulting in a perfect repair of the DNA. Therefore, an exogenous repair template with the desired alteration, such as the insertion of an antibiotic resistance selection marker, can be delivered into the cell to allow for homologous recombination repair to replace the endogenous segment. For genes whose phenotype cannot be predicted, the use of dDNA can facilitate faster and more efficient screening for transformants. In this study, we disrupted a candidate virulence gene from D. septosporum which codes for a small, secreted cell death elicitor. For Ds74283 disruption, we co-transformed D. septosporum with the same autonomously replicating plasmid containing the Cas9 endonuclease gene as used for AflR, along with the specific sgRNA and a dDNA plasmid harboring a selective resistance marker, with flanking arms of approximately 1 kb. We found successful disruption of Ds74283 in all stable transformants tested.
The strategy that we used for Ds74283 CRISPR/Cas9 disruption was successfully used in different fungal and oomycete species. In Phytophthora sojae, homologous recombination was stimulated using the nptII gene in between 1 kb flanking sequences from the candidate gene, as used in our study [14]. The combination of a Cas9 protein and dDNA-sgRNA expression plasmid resulted in almost 90% of Colletotrichum sansevieriae transformants with the candidate gene disrupted [37], with flanking sequences (1–1.5 kb) resulting in efficient dDNA recombination. However, shorter flanking arms can also work efficiently; 100% efficiency of homologous integration of the dDNA in CRISPR/Cas9 transformation of Beauveria bassiana was obtained when 250 bp flanking sequences were used [38].
For D. septosporum CRISPR/Cas9 transformation with dDNA, PCR analysis indicated very high frequency of homologous recombination, with all transformants having the correctly sized band corresponding to the integration of the nptII cassette. Southern blot analysis, however, revealed that even though Ds74283 was disrupted in all transformants tested, all of them had extra hybridising fragments. None of those fragments matched in size with the integration of an extra copy of the selective marker cassette, or partial digestion of genomic DNA. These extra fragments might be due to partial integration of parts of the dDNA in other regions of the genome which are therefore also being targeted by the hybridisation probe. Nevertheless, we successfully disrupted Ds74283 and detected the expected size of disruption band in two independent transformants.
CRISPR/Cas9 disruption of D. septosporum was very efficient using both the NHEJ and dDNA homologous recombination repair mechanisms. If the phenotype of a mutant is known, and the aim is simple disruption of the gene, we recommend using the NHEJ repair system. If the phenotype is not known, using the dDNA-mediated homologous recombination repair is the best option. However, in both systems, we observed unusual effects from CRISPR/Cas9 disruption, including the insertion of the CRISPR plasmid, and additional fragments. Reducing the time spent growing transformants on selective media would reduce the selective pressure for integration of DNA containing selectable marker genes and most likely lead to cleaner disruption mutants. In experiments where the effects of CRISPR/Cas9 mutation must be fully understood, whole-genome sequencing may be needed to determine if there are off-target mutations.
To the best of our knowledge, our research is the first to report successful and efficient CRISPR/Cas9 transformation in a Dothideomycete forest pathogen. This work enables investigation of the role of the Ds74283 cell death elicitor by determining the virulence of Ds74283 mutants on pine. More broadly, CRISPR/Cas9 technology also accelerates functional studies of other putative virulence candidates in D. septosporum‒pine interactions [6]. This enables us to address complex questions such as what triggers the transition from biotrophy to necrotrophy in this hemibiotrophic pathogen [8].
CRISPR/Cas9 technology has immense potential in the development of new methods of plant disease control in general, but is greatly underutilised in forest pathosystems largely due to the complexities of tree genomes and the long life cycles of trees [2]. However, disease control can be improved by the application of CRISPR/Cas9 to forest pathogens and the trees themselves [2]. CRISPR/Cas9 provides an efficient tool for functional analysis of potential disease-related pathogen genes that can be used in turn to identify plant host targets and decipher the complexities of plant‒pathogen interactions [2,14]. Furthermore, pathogen genes that are found to have virulence functions, thanks to functional analysis by CRISPR/Cas9 mutagenesis, could also be deployed for developing new methods of disease control, for example by serving as targets for RNA-induced gene silencing, potentially restricting pathogen growth [39,40]. We hope the success we report in D. septosporum encourages the use of CRISPR/Cas9 technology in other forest pathogens and contribute to the global fight for forest health.

4. Materials and Methods

4.1. Culturing of Dothistroma septosporum

WT D. septosporum strain NZE10 was used in this study. WT fungus and CRISPR/Cas9 transformants were routinely cultured on Dothistroma medium (DM) [41] at 22 °C for 7 days. Culturing was performed by grinding mycelium in sterile water and spreading it over the plate. To facilitate visual phenotype screening for dothistromin production in AflR transformants, the DM medium was supplemented with 100 µg/mL CuSO4.5H2O to elevate dothistromin production (Figure 1 and Figure S2). For single-spore purification of AflR CRISPR/Cas9 transformants, sterile water was added to a sporulating plate for 10 min, then spores collected by pipetting and streaked onto a new plate. Two rounds of spore purification were performed. For the purification of Ds74283 CRISPR/Cas9 transformants, ground mycelium was used instead of spores (two rounds performed). Mycelium for gDNA extraction was harvested by either culturing onto a DM plate with cellophane and scraping off mycelium when grown or inoculating 25 mL of DM broth in a 125 mL flask with ~200 µL ground mycelium, incubating for 7 days at 22 °C, shaking at 160 rpm, and harvesting the mycelium through a sterile nappy liner.

4.2. Construction of CRISPR/Cas9 Plasmid

CRISPR sgRNA selection is an important part of the CRISPR/Cas9 transformation process that can impact the transformation efficiency. Two sgRNAs targeting the AflR gene, and one targeting Ds74283, were selected from the first exon (Table 1) to maximise the effects of any frameshift mutations that might be caused during DSB repair [42]. sgRNAs were identified using the “find CRISPR sites” tool in Geneious (v9.1.8 software) and selected for the highest on-target activity score and an off-target score of 100% (Table 1). After sgRNAs had been selected, they were produced and inserted into the CRISPR plasmid Cas9HygAMAccdB using previously described methods [26]. Plasmids were screened after insertion of the sgRNA and sequenced with primer M139 and the reverse gRNA primer. All primers used in this study are detailed in Table S1.

4.3. Construction of Donor DNA Plasmid for Homologous Recombination

The dDNA (template for homologous recombination) was constructed with two flanks from the gene of interest (Ds74283), with the nptII cassette (PtrpC-nptII-TtrpC) in between. The 5′ flank (from nucleotide 714,367 to 715,332 on scaffold 9) and 3′ flank (from nucleotide 715,340 to 716,198 on scaffold 9) both start 3 bp from the DSB (which occurs 3 bp downstream from the PAM site) [19]. The nptII cassette was amplified from plasmid pII99 [45], while plasmid pAN7-1 [46], which is a Gibson Assembly-compatible plasmid, was the backbone for dDNA assembly. The 966 bp 5′ and 859 bp 3′ flanks of Ds74283 were amplified from WT NZE10 D. septosporum genomic DNA by PCR. The 2808 bp resistance marker sequence was amplified from plasmid pII99, and the 2591 bp backbone vector sequence was amplified from plasmid pAN7-1. All PCRs were performed with Phusion High-Fidelity DNA polymerase (New England Biolabs, Ipswich, MA, USA). Fragments were then assembled via Gibson Assembly [47], and the correct assembly was verified by sequencing. The resulting dDNA plasmid was linearised with the NdeI (New England Biolabs) restriction enzyme prior to fungal transformation.

4.4. Generation of Dothistroma septosporum Protoplasts and PEG Transformation

Protoplasts were generated from D. septosporum as reported previously [48], except that flasks were initially inoculated with mycelial fragments and incubated at 22 °C for 6–7 days. To digest cell walls, 10 mg/mL Glucanex lysing enzyme (Novozymes, Copenhagen, Denmark) was used, and flasks incubated at 30 °C for 12–16 h with shaking at 100 rpm. Transformation was performed as reported previously [48] with several additions. Protoplasts were diluted to 1.25 × 108 protoplasts/mL in STC buffer [48] then, to 80 µL of protoplast suspension, 20 µL 40% polyethylene glycol (PEG) solution (40% PEG 4000, 50 mM CaCl2, 50 mM Tris-HCl, 1M sorbitol) was added. For transformation without a dDNA template, 5 µg Cas9HygAMAccdB plasmid (1 µg/µL) was added, while for transformation with dDNA, 3 µg of Cas9HygAMAccdB plasmid and 5 µg of linearised dDNA were added. The protoplast mixture was vortexed briefly and left on ice for 30 min. Then, 900 µL 40% PEG solution was added, mixed, and left at room temperature (~20 °C) for 20 min. Protoplasts were then plated by mixing 100 µL protoplast solution with 3.5 mL molten (50 °C) regeneration medium (RG: 50 g/L malt extract (Oxoid, Basingstoke, UK), 23 g/L nutrient broth (Oxoid), 0.8 M sucrose, 0.8% bacteriological agar (Pure Science, Wellington, New Zealand)) and overlaying an RG plate (15 mL, 1.5% bacteriological agar). Plates were incubated overnight at 22 °C, then a 5 mL overlay of 0.8% RG was added containing antibiotics for the entire plate (70 µg/mL hygromycin B (Roche, Basel, Switzerland), and 100 µg/mL geneticin (Life Technologies, Carlsbad, CA, USA) if using dDNA). Plates were incubated at 22 °C for at least 2 weeks before colonies appeared. Colonies that grew on the AflR transformation plates were transferred to 12-well plates containing DM with 70 µg/mL hygromycin B. Colonies were then subcultured to standard DM plates with hygromycin B and single spore purification was performed. Where dDNA was used, colonies were transferred to 12-well plates containing DM with 70 µg/mL hygromycin B and 100 µg/mL geneticin and then subcultured to DM plates with geneticin for purification using ground mycelium and maintained on nonselective DM.

4.5. Screening of Transformants by PCR, Southern Hybridisation, Sequencing and Thin Layer Chromatography

Genomic DNA was initially extracted using a crude method to facilitate screening [49], then later, extractions were performed as described by Doyle and Doyle [50] or by van Kan et al. [51]. Transformants were screened by PCR using gDNA as template and Taq DNA polymerase with ThermoPol Buffer (New England Biolabs) following the manufacturer’s protocols. PCRs from which products would be sequenced used Phusion High-Fidelity DNA Polymerase as per the manufacturer’s protocols. PCR amplicon sequencing was performed by the Massey Genome Service (Massey University, Palmerston North, New Zealand).
Confirmation of gene disruption was achieved by Southern hybridisation with a digoxigenin (DIG)-labelled probe using the DIG High Prime DNA Labelling and Detection Starter Kit I (Roche). Approx. 2 µg of genomic DNA from WT D. septosporum and transformants of this fungus was digested at 37 °C overnight with the restriction enzymes HindIII, NcoI or XhoI (New England Biolabs) and run overnight on a 0.8% agarose gel. After that, DNA was transferred to a positively charged nylon membrane (Roche) and blotted overnight according to Southern et al. [52]. Color detection was performed by enzyme immunoassay using the DIG High Prime DNA Labelling and Detection Starter Kit I (Roche), following manufacturer’s instructions.
The presence of dothistromin was assayed by thin-layer chromatography (TLC) as reported previously [11], except that flasks were inoculated with mycelial fragments, incubated for 7 days, and the TLC was run in toluene:acetone (80:20) solvent acidified with 1% formic acid.

5. Conclusions

In this study, we have successfully performed CRISPR/Cas9 gene editing in the Dothideomycete forest pathogen D. septosporum. We report efficient gene disruption of >90% when using non-homologous end-joining repair, and 100% in screened transformants that used homologous recombination repair with a donor DNA template. Establishment of CRISPR/Cas9 in D. septosporum will greatly facilitate characterisation of effectors from this pathogen, and aid the development of this method in other forest pathogens and Dothideomycete species.

Supplementary Materials

The following are available online at https://www.mdpi.com/article/10.3390/plants11081016/s1. Figure S1: PCR screen of Dothistroma septosporum AflR CRISPR/Cas9 transformants to amplify full-length AflR gene sequence; Figure S2: increased production of dothistromin by Dothistroma septosporum in the presence of 100 µg/mL CuSO4.5H2O; Figure S3: Southern hybridisation analysis of Dothistroma septosporum AflR CRISPR/Cas9 transformants; Figure S4: PCR analysis to support estimated insertion size and content of Dothistroma septosporum AflR CRISPR/Cas9 transformants 82 and 158; Figure S5: Dothistroma septosporum candidate effector Ds74283 induces cell death in Pinus radiata; Figure S6: PCR screening to further characterise five Dothistroma septosporum CRISPR/Cas9 Ds74283 transformants. Table S1: primers used in this study.

Author Contributions

Conceptualisation, R.E.B. and C.H.M.; methodology, H.M.M. and M.T.; validation, H.M.M., M.T., C.H.M. and R.E.B.; investigation, H.M.M. and M.T.; resources, R.L.M.; writing—original draft preparation, H.M.M., M.T. and R.E.B.; writing—review and editing, H.M.M., M.T., C.H.M., R.L.M. and R.E.B.; visualisation, H.M.M. and M.T.; supervision, R.E.B., R.L.M. and C.H.M.; project administration, R.E.B., C.H.M. and R.L.M.; funding acquisition, R.E.B. and R.L.M. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by a Massey University Ph.D. scholarship for H.M. (funding number 14013350), by Scion (NZFRI, Ltd. (Rotorua, New Zealand)), for M.T. and R.L.M. through the Resilient Forests Research Program via Strategic Science Investments Funds from the New Zealand Ministry of Business Innovation and Employment (MBIE), grant number CO4X1703, and New Zealand Forest Grower Levy Trust funding, grant number QT-9108.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

The data presented in this study are available in article and supplementary material.

Acknowledgments

The Radiata Pine Breeding Company is acknowledged for the permission to use pine material. Richard Johnson and Linda Johnson (AgResearch, Palmerston North, New Zealand) are acknowledged for providing the Cas9HygAMAccdB plasmid. Pranav Chettri (AgResearch, Palmerston North, New Zealand) is acknowledged for his advice on performing TLC analysis and CRISPR/Cas9 gene editing. Mercedes Rocafort (Massey University, Palmerston North, New Zealand) is acknowledged for her advice on performing CRISPR/Cas9 gene editing.

Conflicts of Interest

The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.

References

  1. Urban, M.; Cuzick, A.; Seager, J.; Wood, V.; Rutherford, K.; Venkatesh, S.Y.; De Silva, N.; Martinez, M.C.; Pedro, H.; Yates, A.D.; et al. PHI-base: The pathogen–host interactions database. Nucleic Acids Res. 2020, 48, 613–620. [Google Scholar] [CrossRef] [PubMed]
  2. Dort, E.N.; Tanguay, P.; Hamelin, R.C. CRISPR/Cas9 gene editing: An unexplored frontier for forest pathology. Front. Plant Sci. 2020, 11, 1126. [Google Scholar] [CrossRef] [PubMed]
  3. Guo, Y.; Hunziker, L.; Mesarich, C.H.; Chettri, P.; Dupont, P.-Y.; Ganley, R.J.; McDougal, R.L.; Barnes, I.; Bradshaw, R.E. DsEcp2-1 is a polymorphic effector that restricts growth of Dothistroma septosporum in pine. Fungal Genet. Biol. 2020, 135, 103300. [Google Scholar] [CrossRef] [PubMed]
  4. Drenkhan, R.; Tomešová-Haataja, V.; Fraser, S.; Bradshaw, R.E.; Vahalík, P.; Mullett, M.S.; Martín-García, J.; Bulman, L.S.; Wingfield, M.J.; Kirisits, T.; et al. Global geographic distribution and host range of Dothistroma species: A comprehensive review. For. Pathol. 2016, 46, 408–442. [Google Scholar] [CrossRef]
  5. Woods, A.J.; Martín-García, J.; Bulman, L.; Vasconcelos, M.W.; Boberg, J.; La Porta, N.; Peredo, H.; Vergara, G.; Ahumada, R.; Brown, A.; et al. Dothistroma needle blight, weather and possible climatic triggers for the disease’s recent emergence. For. Pathol. 2016, 46, 443–452. [Google Scholar] [CrossRef] [Green Version]
  6. Hunziker, L.; Tarallo, M.; Gough, K.; Guo, M.; Hargreaves, C.; Loo, T.S.; McDougal, R.L.; Mesarich, C.H.; Bradshaw, R.E. Apoplastic effector candidates of a foliar forest pathogen trigger cell death in host and non-host plants. Sci. Rep. 2021, 11, 19958. [Google Scholar] [CrossRef]
  7. de Wit, P.J.G.M.; van der Burgt, A.; Ökmen, B.; Stergiopoulos, I.; Abd-Elsalam, K.A.; Aerts, A.L.; Bahkali, A.H.; Beenen, H.G.; Chettri, P.; Cox, M.P.; et al. The genomes of the fungal plant pathogens Cladosporium fulvum and Dothistroma septosporum reveal adaptation to different hosts and lifestyles but also signatures of common ancestry. PLoS Genet. 2012, 8, e1003088. [Google Scholar] [CrossRef]
  8. Bradshaw, R.E.; Guo, Y.; Sim, A.D.; Kabir, M.S.; Chettri, P.; Ozturk, I.K.; Hunziker, L.; Ganley, R.J.; Cox, M.P. Genome-wide gene expression dynamics of the fungal pathogen Dothistroma septosporum throughout its infection cycle of the gymnosperm host Pinus radiata. Mol. Plant Pathol. 2016, 17, 210–224. [Google Scholar] [CrossRef] [Green Version]
  9. Kabir, M.S.; Ganley, R.J.; Bradshaw, R.E. Dothistromin toxin is a virulence factor in dothistroma needle blight of pines. Plant Pathol. 2015, 64, 225–234. [Google Scholar] [CrossRef]
  10. Ozturk, I.K.; Dupont, P.Y.; Chettri, P.; McDougal, R.; Böhl, O.J.; Cox, R.J.; Bradshaw, R.E. Evolutionary relics dominate the small number of secondary metabolism genes in the hemibiotrophic fungus Dothistroma septosporum. Fungal Biol. 2019, 123, 397–407. [Google Scholar] [CrossRef]
  11. Chettri, P.; Calvo, A.M.; Cary, J.W.; Dhingra, S.; Guo, Y.; McDougal, R.L.; Bradshaw, R.E. The veA gene of the pine needle pathogen Dothistroma septosporum regulates sporulation and secondary metabolism. Fungal Genet. Biol. 2012, 49, 141–151. [Google Scholar] [CrossRef] [PubMed]
  12. Chettri, P.; Dupont, P.Y.; Bradshaw, R.E. Chromatin-level regulation of the fragmented dothistromin gene cluster in the forest pathogen Dothistroma septosporum. Mol. Microbiol. 2018, 107, 508–522. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  13. Liu, R.; Chen, L.; Jiang, Y.; Zhou, Z.; Zou, G. Efficient genome editing in filamentous fungus Trichoderma reesei using the CRISPR/Cas9 system. Cell Discov. 2015, 1, 15007. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  14. Fang, Y.; Tyler, B.M. Efficient disruption and replacement of an effector gene in the oomycete Phytophthora sojae using CRISPR/Cas9. Mol. Plant Pathol. 2016, 17, 127–139. [Google Scholar] [CrossRef]
  15. Mojica, F.J.; Díez-Villaseñor, C.; García-Martínez, J.; Soria, E. Intervening sequences of regularly spaced prokaryotic repeats derive from foreign genetic elements. J. Mol. Evol. 2005, 60, 174–182. [Google Scholar] [CrossRef]
  16. Barrangou, R.; Fremaux, C.; Deveau, H.; Richards, M.; Boyaval, P.; Moineau, S.; Romero, D.A.; Horvath, P. CRISPR provides acquired resistance against viruses in prokaryotes. Science 2007, 315, 1709–1712. [Google Scholar] [CrossRef]
  17. Brouns, S.J.J.; Jore, M.M.; Lundgren, M.; Westra, E.R.; Slijkhuis, R.J.H.; Snijders, A.P.L.; Dickman, M.J.; Makarova, K.S.; Koonin, E.V.; van der Oost, J. Small CRISPR RNAs guide antiviral defense in prokaryotes. Science 2008, 321, 960–963. [Google Scholar] [CrossRef] [Green Version]
  18. Deveau, H.; Barrangou, R.; Garneau Josiane, E.; Labonté, J.; Fremaux, C.; Boyaval, P.; Romero Dennis, A.; Horvath, P.; Moineau, S. Phage response to CRISPR-encoded resistance in Streptococcus thermophilus. J. Bacteriol. 2008, 190, 1390–1400. [Google Scholar] [CrossRef] [Green Version]
  19. Jinek, M.; Chylinski, K.; Fonfara, I.; Hauer, M.; Doudna, J.A.; Charpentier, E. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science 2012, 337, 816–821. [Google Scholar] [CrossRef]
  20. Gasiunas, G.; Barrangou, R.; Horvath, P.; Siksnys, V. Cas9–crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria. Proc. Natl. Acad. Sci. USA 2012, 109, E2579. [Google Scholar] [CrossRef] [Green Version]
  21. Schuster, M.; Kahmann, R. CRISPR-Cas9 genome editing approaches in filamentous fungi and oomycetes. Fungal Genet. Biol. 2019, 130, 43–53. [Google Scholar] [CrossRef] [PubMed]
  22. Gosavi, G.; Yan, F.; Ren, B.; Kuang, Y.; Yan, D.; Zhou, X.; Zhou, H. Applications of CRISPR technology in studying plant-pathogen interactions: Overview and perspective. Phytopathol. Res. 2020, 2, 21. [Google Scholar] [CrossRef]
  23. Wenderoth, M.; Pinecker, C.; Voß, B.; Fischer, R. Establishment of CRISPR/Cas9 in Alternaria alternata. Fungal Genet. Biol. 2017, 101, 55–60. [Google Scholar] [CrossRef] [PubMed]
  24. Idnurm, A.; Urquhart, A.S.; Vummadi, D.R.; Chang, S.; Van de Wouw, A.P.; López-ruiz, F.J. Spontaneous and CRISPR/Cas9-induced mutation of the osmosensor histidine kinase of the canola pathogen Leptosphaeria maculans. Fungal Biol. Biotechnol. 2017, 4, 1–12. [Google Scholar] [CrossRef] [PubMed]
  25. Khan, H.; McDonald, M.C.; Williams, S.J.; Solomon, P.S. Assessing the efficacy of CRISPR/Cas9 genome editing in the wheat pathogen Parastagonspora nodorum. Fungal Biol. Biotechnol. 2020, 7, 4. [Google Scholar] [CrossRef]
  26. Rocafort, M.; Arshed, S.; Hudson, D.; Sidhu, J.S.; Bowen, J.K.; Plummer, K.M.; Bradshaw, R.E.; Johnson, R.D.; Johnson, L.J.; Mesarich, C.H. CRISPR-Cas9 gene editing and rapid detection of gene-edited mutants using high-resolution melting in the apple scab fungus, Venturia inaequalis. Fungal Biol. 2022, 126, 35–46. [Google Scholar] [CrossRef]
  27. Kariyawasam, G.K.; Richards, J.K.; Wyatt, N.A.; Running, K.L.D.; Xu, S.S.; Liu, Z.; Borowicz, P.; Faris, J.D.; Friesen, T.L. The Parastagonospora nodorum necrotrophic effector SnTox5 targets the wheat gene Snn5 and facilitates entry into the leaf mesophyll. New Phytol. 2021, 1, 409–426. [Google Scholar] [CrossRef]
  28. Chettri, P.; Ehrlich, K.C.; Cary, J.W.; Collemare, J.; Cox, M.P.; Griffiths, S.A.; Olson, M.A.; de Wit, P.J.G.M.; Bradshaw, R.E. Dothistromin genes at multiple separate loci are regulated by AflR. Fungal Genet. Biol. 2013, 51, 12–20. [Google Scholar] [CrossRef]
  29. Krappmann, S. Gene targeting in filamentous fungi: The benefits of impaired repair. Fungal Biol. Rev. 2007, 21, 25–29. [Google Scholar] [CrossRef]
  30. Tanguay, P. CRISPR/Cas9 gene editing of the Dutch elm disease pathogen Ophiostoma novo-ulmi. Can. J. Plant Pathol. 2019, 41, 163. [Google Scholar] [CrossRef]
  31. Zhang, H.; Shen, W.; Zhang, D.; Shen, X.; Wang, F.; Hsiang, T.; Liu, J.; Li, G. The bZIP transcription factor LtAP1 modulates oxidative stress tolerance and virulence in the peach gummosis fungus Lasiodiplodia theobromae. Front. Microbiol. 2021, 12, 741842. [Google Scholar] [CrossRef] [PubMed]
  32. Liu, F.; Selin, C.; Zou, Z.; Dilantha Fernando, W.G. LmCBP1, a secreted chitin-binding protein, is required for the pathogenicity of Leptosphaeria maculans on Brassica napus. Fungal Genet. Biol. 2020, 136, 103320. [Google Scholar] [CrossRef] [PubMed]
  33. Fuller, K.K.; Chen, S.; Loros, J.J.; Dunlap, J.C. Development of the CRISPR/Cas9 system for targeted gene disruption in Aspergillus fumigatus. Eukaryot. Cell 2015, 14, 1073–1080. [Google Scholar] [CrossRef] [Green Version]
  34. Zheng, Y.M.; Lin, F.L.; Gao, H.; Zou, G.; Zhang, J.W.; Wang, G.Q.; Chen, G.D.; Zhou, Z.H.; Yao, X.S.; Hu, D. Development of a versatile and conventional technique for gene disruption in filamentous fungi based on CRISPR-Cas9 technology. Sci. Rep. 2017, 7, 9250. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  35. Li, J.; Zhang, Y.; Zhang, Y.; Yu, P.-L.; Pan, H.; Rollins Jeffrey, A.; Vidaver Anne, K. Introduction of large sequence inserts by CRISPR-Cas9 to create pathogenicity mutants in the multinucleate filamentous pathogen Sclerotinia sclerotiorum. MBio 2018, 9, e00567-18. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  36. Boontawon, T.; Nakazawa, T.; Inoue, C.; Osakabe, K.; Kawauchi, M.; Sakamoto, M.; Honda, Y. Efficient genome editing with CRISPR/Cas9 in Pleurotus ostreatus. AMB Express 2021, 11, 30. [Google Scholar] [CrossRef] [PubMed]
  37. Nakamura, M.; Okamura, Y.; Iwai, H. Plasmid-based and -free methods using CRISPR/Cas9 system for replacement of targeted genes in Colletotrichum sansevieriae. Sci. Rep. 2019, 9, 18947. [Google Scholar] [CrossRef] [Green Version]
  38. Chen, J.; Lai, Y.; Wang, L.; Zhai, S.; Zou, G.; Zhou, Z.; Cui, C.; Wang, S. CRISPR/Cas9-mediated efficient genome editing via blastospore-based transformation in entomopathogenic fungus Beauveria bassiana. Sci. Rep. 2017, 8, 45763. [Google Scholar] [CrossRef]
  39. McLoughlin, A.G.; Wytinck, N.; Walker, P.L.; Girard, I.J.; Rashid, K.Y.; de Kievit, T.; Fernando, W.G.D.; Whyard, S.; Belmonte, M.F. Identification and application of exogenous dsRNA confers plant protection against Sclerotinia sclerotiorum and Botrytis cinerea. Sci. Rep. 2018, 8, 7320. [Google Scholar] [CrossRef]
  40. Makarova, S.S.; Khromov, A.V.; Spechenkova, N.A.; Taliansky, M.E.; Kalinina, N.O. Application of the CRISPR/Cas system for generation of pathogen-resistant plants. Biochemistry 2018, 83, 1552–1562. [Google Scholar] [CrossRef]
  41. Bradshaw, R.; Ganley, R.; Jones, W.; Dyer, P. High levels of dothistromin toxin produced by the forest pathogen Dothistroma pini. Mycol. Res. 2000, 104, 325–332. [Google Scholar] [CrossRef]
  42. Doench, J.G.; Hartenian, E.; Graham, D.B.; Tothova, Z.; Hegde, M.; Smith, I.; Sullender, M.; Ebert, B.L.; Xavier, R.J.; Root, D.E. Rational design of highly active sgRNAs for CRISPR-Cas9-mediated gene inactivation. Nat. Biotechnol. 2014, 32, 1262–1267. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  43. Hsu, P.D.; Scott, D.A.; Weinstein, J.A.; Ran, F.A.; Konermann, S.; Agarwala, V.; Li, Y.; Fine, E.J.; Wu, X.; Shalem, O.; et al. DNA targeting specificity of RNA-guided Cas9 nucleases. Nat. Biotechnol. 2013, 31, 827–832. [Google Scholar] [CrossRef] [PubMed]
  44. Doench, J.G.; Fusi, N.; Sullender, M.; Hegde, M.; Vaimberg, E.W.; Donovan, K.F.; Smith, I.; Tothova, Z.; Wilen, C.; Orchard, R.; et al. Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9. Nat. Biotechnol. 2016, 34, 184–191. [Google Scholar] [CrossRef] [Green Version]
  45. Lara-Ortíz, T.; Riveros-Rosas, H.; Aguirre, J. Reactive oxygen species generated by microbial NADPH oxidase NoxA regulate sexual development in Aspergillus nidulans. Mol. Microbiol. 2003, 50, 1241–1255. [Google Scholar] [CrossRef] [Green Version]
  46. Punt, P.J.; Dingemanse, M.A.; Kuyvenhoven, A.; Soede, R.D.; Pouwels, P.H.; van den Hondel, C.A. Functional elements in the promoter region of the Aspergillus nidulans gpdA gene encoding glyceraldehyde-3-phosphate dehydrogenase. Gene 1990, 93, 101–109. [Google Scholar] [CrossRef]
  47. Gibson, D.G.; Young, L.; Chuang, R.Y.; Venter, J.C.; Hutchison, C.A.; Smith, H.O. Enzymatic assembly of DNA molecules up to several hundred kilobases. Nat. Methods 2009, 6, 343–345. [Google Scholar] [CrossRef]
  48. Bradshaw, R.E.; Bidlake, A.; Forester, N.; Scott, D.B. Transformation of the fungal forest pathogen Dothistroma pini to hygromycin resistance. Mycol. Res. 1997, 101, 1247–1250. [Google Scholar] [CrossRef]
  49. Liu, D.; Coloe, S.; Baird, R.; Pederson, J. Rapid mini-preparation of fungal DNA for PCR. J. Clin. Microbiol. 2000, 38, 471. [Google Scholar] [CrossRef]
  50. Doyle, J.J.; Doyle, J.L. A rapid DNA isolation procedure for small quantities of fresh leaf tissue. Phytochem. Bull. 1987, 19, 11–15. [Google Scholar]
  51. van Kan, J.A.; van den Ackerveken, G.F.; de Wit, P.J. Cloning and characterization of cDNA of avirulence gene avr9 of the fungal pathogen Cladosporium fulvum, causal agent of tomato leaf mold. Mol. Plant Microbe Interact. 1991, 4, 52–59. [Google Scholar] [CrossRef] [PubMed]
  52. Southern, E.M. Detection of specific sequences among DNA fragments separated by gel electrophoresis. J. Mol. Biol. 1975, 98, 503–517. [Google Scholar] [CrossRef]
Figure 1. Presence or absence of dothistromin from wild-type (WT) Dothistroma septosporum and CRISPR/Cas9 AflR transformants selected for investigation. (a) Visual analysis of dothistromin production when grown on Dothistroma medium (DM) supplemented with 100 µg/mL CuSO4.5H2O (known to enhance dothistromin production; Figure S2). Presence of dothistromin shown by red-brown pigmentation of the media, as seen in DM supporting growth of WT fungus, and transformants 45 and 144. Transformants were photographed 4 weeks postinoculation. (b) Thin-layer chromatography (TLC) analysing dothistromin production in AflR transformants and WT fungus. Position of dothistromin is shown in standard (Std), highlighted with a white asterisk. Dothistromin was visible in samples representing WT fungus, and transformants 45 and 144.
Figure 1. Presence or absence of dothistromin from wild-type (WT) Dothistroma septosporum and CRISPR/Cas9 AflR transformants selected for investigation. (a) Visual analysis of dothistromin production when grown on Dothistroma medium (DM) supplemented with 100 µg/mL CuSO4.5H2O (known to enhance dothistromin production; Figure S2). Presence of dothistromin shown by red-brown pigmentation of the media, as seen in DM supporting growth of WT fungus, and transformants 45 and 144. Transformants were photographed 4 weeks postinoculation. (b) Thin-layer chromatography (TLC) analysing dothistromin production in AflR transformants and WT fungus. Position of dothistromin is shown in standard (Std), highlighted with a white asterisk. Dothistromin was visible in samples representing WT fungus, and transformants 45 and 144.
Plants 11 01016 g001
Figure 2. PCR screening to characterise Dothistroma septosporum AflR CRISPR/Cas9 transformants. (a) Primers used to screen the AflR region. Green bar is AflR, and black bars are flanking genes, labelled with either name or JGI protein ID. Positions of primers are illustrated by grey flags with the primer name above. Distances between the primer pairs shown above the primers. (b) PCR screen of AflR gene and intergenic region between AflR and Ds140271. (c) PCR screen of genes upstream and downstream of AflR. Name of each transformant screened shown at the top of each group of gel pictures. PCR products larger than wild-type (WT)-sized PCR products labelled with a white asterisk. Relevant labels of the DNA ladder shown to the right of each gel picture, and primers used in each PCR shown on the left.
Figure 2. PCR screening to characterise Dothistroma septosporum AflR CRISPR/Cas9 transformants. (a) Primers used to screen the AflR region. Green bar is AflR, and black bars are flanking genes, labelled with either name or JGI protein ID. Positions of primers are illustrated by grey flags with the primer name above. Distances between the primer pairs shown above the primers. (b) PCR screen of AflR gene and intergenic region between AflR and Ds140271. (c) PCR screen of genes upstream and downstream of AflR. Name of each transformant screened shown at the top of each group of gel pictures. PCR products larger than wild-type (WT)-sized PCR products labelled with a white asterisk. Relevant labels of the DNA ladder shown to the right of each gel picture, and primers used in each PCR shown on the left.
Plants 11 01016 g002
Figure 3. Summary of mutations identified from Dothistroma septosporum AflR CRISPR/Cas9 transformants. (a) Visual representation of AflR locus including flanking genes in each transformant. Purple bar in AflR is the CRISPR/Cas9 sgRNA AflR2 binding site. Mutations, if present, indicated by a grey triangle and labelled with type of mutation identified through phenotype, PCR analysis, and PCR amplicon sequencing. (b) Specific locations within sgRNA AflR2 binding site where CRISPR/Cas9 disruptions were observed. sgRNA AflR2 binding site is 23 bp; end with double-strand break (DSB) site (in blue) and protospacer adjacent motif (PAM) site (in green) shown as nucleotides, and the rest illustrated by a purple bar. Where a transformant had an insertion, the insertion start position is shown through truncation of the sgRNA AflR2 binding site sequence. Single-nucleotide deletion in transformant 140 shown by a dash in the sequence. For transformants 105, 157, and 161, no PCR amplification was achieved in the AflR region; therefore, no sequencing was performed (labelled “undefined/unknown”).
Figure 3. Summary of mutations identified from Dothistroma septosporum AflR CRISPR/Cas9 transformants. (a) Visual representation of AflR locus including flanking genes in each transformant. Purple bar in AflR is the CRISPR/Cas9 sgRNA AflR2 binding site. Mutations, if present, indicated by a grey triangle and labelled with type of mutation identified through phenotype, PCR analysis, and PCR amplicon sequencing. (b) Specific locations within sgRNA AflR2 binding site where CRISPR/Cas9 disruptions were observed. sgRNA AflR2 binding site is 23 bp; end with double-strand break (DSB) site (in blue) and protospacer adjacent motif (PAM) site (in green) shown as nucleotides, and the rest illustrated by a purple bar. Where a transformant had an insertion, the insertion start position is shown through truncation of the sgRNA AflR2 binding site sequence. Single-nucleotide deletion in transformant 140 shown by a dash in the sequence. For transformants 105, 157, and 161, no PCR amplification was achieved in the AflR region; therefore, no sequencing was performed (labelled “undefined/unknown”).
Plants 11 01016 g003
Figure 4. Insertions in Dothistroma septosporum CRISPR/Cas9 AflR transformants and matching sequences. (a) Insertions in transformants 145, 82, and 158 that match part of the hph (hygromycin B resistance gene) cassette from the CRISPR/Cas9 plasmid (Cas9HygAMAccdB). (b) Part of insertion in transformant 133 that matches different regions of the CRISPR/Cas9 plasmid and a region of an Escherichia coli strain OP50 chromosome. Insertions were identified by PCR analysis and PCR amplicon sequencing. Insertions indicated by green bars align to matching regions of the Cas9HygAMAccdB plasmid or E. coli chromosome. Grey rectangles or triangles underneath and above insertions indicate relative orientation compared to the AflR gene. HindIII restriction enzymes sites near the hph cassette are labelled. Black lines indicate part of the Cas9HygAMAccdB plasmid sequence or E. coli chromosome, and labelled purple bars indicate genes or plasmid components (TtrpC terminator, hph cassette, PgpdA promoter, AMA1 autonomously replicating sequence, AmpR β-lactamase (ampicillin resistance) gene, Cas9 gene). PCRs performed to support expected insertion sizes and content of transformants 82 and 158 shown in Figure S4.
Figure 4. Insertions in Dothistroma septosporum CRISPR/Cas9 AflR transformants and matching sequences. (a) Insertions in transformants 145, 82, and 158 that match part of the hph (hygromycin B resistance gene) cassette from the CRISPR/Cas9 plasmid (Cas9HygAMAccdB). (b) Part of insertion in transformant 133 that matches different regions of the CRISPR/Cas9 plasmid and a region of an Escherichia coli strain OP50 chromosome. Insertions were identified by PCR analysis and PCR amplicon sequencing. Insertions indicated by green bars align to matching regions of the Cas9HygAMAccdB plasmid or E. coli chromosome. Grey rectangles or triangles underneath and above insertions indicate relative orientation compared to the AflR gene. HindIII restriction enzymes sites near the hph cassette are labelled. Black lines indicate part of the Cas9HygAMAccdB plasmid sequence or E. coli chromosome, and labelled purple bars indicate genes or plasmid components (TtrpC terminator, hph cassette, PgpdA promoter, AMA1 autonomously replicating sequence, AmpR β-lactamase (ampicillin resistance) gene, Cas9 gene). PCRs performed to support expected insertion sizes and content of transformants 82 and 158 shown in Figure S4.
Plants 11 01016 g004
Figure 5. Dothistroma septosporum CRISPR/Cas9 Ds74283 disruption and confirmation by PCR and Southern hybridisation. (a) Schematic diagram showing disruption of Ds74283 and insertion of nptII geneticin gene cassette (PtrpC-nptII-TtrpC) through homologous recombination using donor DNA (dDNA) as template. dDNA constructed with two flanks (5′ and 3′) from Ds74283, starting 3 bp from double-strand break (shown as black vertical line crossing the gene), with nptII cassette in the middle. Positions of primers illustrated by grey flags with primer name above. Restriction enzyme sites and probe binding site used for Southern hybridisation, and fragment sizes expected from disruption of Ds74283 by insertion of the nptII cassette. Red line shows probe binding site. (b) PCR with primers MT95, which binds to the start codon of Ds74283, and MT96, which binds to the stop codon of the gene. Ds74283 mutants should have a product of 3.4 kb, while wild-type (WT) fungus should have one of 0.64 kb. (c) PCR with primers MT97 and MT98, which bind either side of the target genomic region. Ds74283 mutants should have a product of 4.7 kb, and the WT fungus 1.9 kb. Relevant labels of the DNA ladder are shown on the right of each gel. (d,e) Southern hybridisation of digests ((d) HindIII; (e) NcoI) from D. septosporum WT fungus and five candidate Ds74283 mutants, 3, 25, 45, 52 and 56, using a digoxigenin (DIG)-11-dUTP-labeled probe binding to the 3′ flank region of Ds74283 that was present in the dDNA. Expected fragment sizes marked with red asterisk for Ds74283 mutants and black asterisk for WT fungus. Each of the five Ds74283 mutants sampled from independent transformation plates.
Figure 5. Dothistroma septosporum CRISPR/Cas9 Ds74283 disruption and confirmation by PCR and Southern hybridisation. (a) Schematic diagram showing disruption of Ds74283 and insertion of nptII geneticin gene cassette (PtrpC-nptII-TtrpC) through homologous recombination using donor DNA (dDNA) as template. dDNA constructed with two flanks (5′ and 3′) from Ds74283, starting 3 bp from double-strand break (shown as black vertical line crossing the gene), with nptII cassette in the middle. Positions of primers illustrated by grey flags with primer name above. Restriction enzyme sites and probe binding site used for Southern hybridisation, and fragment sizes expected from disruption of Ds74283 by insertion of the nptII cassette. Red line shows probe binding site. (b) PCR with primers MT95, which binds to the start codon of Ds74283, and MT96, which binds to the stop codon of the gene. Ds74283 mutants should have a product of 3.4 kb, while wild-type (WT) fungus should have one of 0.64 kb. (c) PCR with primers MT97 and MT98, which bind either side of the target genomic region. Ds74283 mutants should have a product of 4.7 kb, and the WT fungus 1.9 kb. Relevant labels of the DNA ladder are shown on the right of each gel. (d,e) Southern hybridisation of digests ((d) HindIII; (e) NcoI) from D. septosporum WT fungus and five candidate Ds74283 mutants, 3, 25, 45, 52 and 56, using a digoxigenin (DIG)-11-dUTP-labeled probe binding to the 3′ flank region of Ds74283 that was present in the dDNA. Expected fragment sizes marked with red asterisk for Ds74283 mutants and black asterisk for WT fungus. Each of the five Ds74283 mutants sampled from independent transformation plates.
Plants 11 01016 g005
Table 1. CRISPR/Cas9 sgRNA protospacers used to target for Dothistroma septosporum AflR and Ds74283 genes.
Table 1. CRISPR/Cas9 sgRNA protospacers used to target for Dothistroma septosporum AflR and Ds74283 genes.
sgRNA
Protospacer
Sequence (5′‒3′) 2Binding Site (bp)DirectionOff-Target Sites 3Off-Target Score 4On-Target Activity Score 5
AflR1TCACGCGGCTCAGAGTCGAGCGGExon 1
(10–32)
Forward0100%0.692
AflR2ACAAGAAGCAGCAGATAGGAGGGExon 1
(267–289)
Forward0100%0.703
Ds74283 1GTTGTTGTAGGCAGAGACGAAGGExon 1
(35–57)
Reverse0100%0.635
1 Joint Genome Institute (JGI) ID of Dothistroma septosporum protein coding for the candidate gene of interest for disruption. 2 Underlined bases are the protospacer adjacent motif (PAM) site. 3 Off-targets found in the coding sequence (CDS). 4 Off-target score calculated using Geneious (v9.1.8) by scoring against the D. septosporum genome, where scores are between 1 and 100 and a high score indicates less off-target activity [43]. 5 On-target activity score based on sequence features of the sgRNA, calculated using Geneious (v9.1.8). Score was 0–1, with a score closer to 1 indicating higher activity [44].
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

McCarthy, H.M.; Tarallo, M.; Mesarich, C.H.; McDougal, R.L.; Bradshaw, R.E. Targeted Gene Mutations in the Forest Pathogen Dothistroma septosporum Using CRISPR/Cas9. Plants 2022, 11, 1016. https://doi.org/10.3390/plants11081016

AMA Style

McCarthy HM, Tarallo M, Mesarich CH, McDougal RL, Bradshaw RE. Targeted Gene Mutations in the Forest Pathogen Dothistroma septosporum Using CRISPR/Cas9. Plants. 2022; 11(8):1016. https://doi.org/10.3390/plants11081016

Chicago/Turabian Style

McCarthy, Hannah M., Mariana Tarallo, Carl H. Mesarich, Rebecca L. McDougal, and Rosie E. Bradshaw. 2022. "Targeted Gene Mutations in the Forest Pathogen Dothistroma septosporum Using CRISPR/Cas9" Plants 11, no. 8: 1016. https://doi.org/10.3390/plants11081016

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop